Coadministration of cure single dose simple 1200 mg information had no statistically significant effect on the pharmacokinetics Macrozit indinavir administered as 800 mg three times daily for 5 days. Therefore, susceptibility testing is considered a precondition for treatment of soft tissue infections with azithromycin. Prolonged use can lead to the growth of dangerous organisms that are resistant to azithromycin.
Possible side effects of Macrozit include:
Macrozit is used to treat diseases such as: Babesiosis, Bacterial Endocarditis Prevention, Bacterial Infection, Bartonellosis, Bronchitis, Cervicitis, Chancroid, Chlamydia Infection, COPD, Acute, Cystic Fibrosis, Gonococcal Infection, Uncomplicated, Granuloma Inguinale, Legionella Pneumonia, Lyme Disease, Erythema Chronicum Migrans, Mycobacterium avium-intracellulare, Prophylaxis, Mycobacterium avium-intracellulare, Treatment, Mycoplasma Pneumonia, Nongonococcal Urethritis, Otitis Media, Pelvic Inflammatory Disease, Pertussis, Pertussis Prophylaxis, Pharyngitis, Pneumonia, Sinusitis, Skin and Structure Infection, Skin or Soft Tissue Infection, STD Prophylaxis, Tonsillitis/Pharyngitis, Toxoplasmosis, Typhoid Fever, Upper Respiratory Tract Infection.
To treat more severe urinary tract infections or infections that happen repeatedly, the dose is usually 100 mg every 6 hours for 7 days.